A Phase 1/Single Ascending Dose (SAD) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of a Single Intraoperative Administration of CA-008 in Subjects Undergoing Unilateral Transpositional First Metatarsal Osteotomy for the Correction of Hallux Valgus Deformity

Trial Profile

A Phase 1/Single Ascending Dose (SAD) Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of a Single Intraoperative Administration of CA-008 in Subjects Undergoing Unilateral Transpositional First Metatarsal Osteotomy for the Correction of Hallux Valgus Deformity

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Jul 2018

At a glance

  • Drugs CA-008 (Primary)
  • Indications Postoperative pain
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Sponsors Concentric Analgesics
  • Most Recent Events

    • 16 Jul 2018 Status changed from active, no longer recruiting to completed.
    • 14 May 2018 According to a Concentric Analgesics media release, the company anticipates presenting complete data, including pharmacokinetics and full 28-day follow-up results, from the trial later in 2018.
    • 14 May 2018 According to a Concentric Analgesics media release, Neil Singla has conducted this trial at Huntington Memorial Hospital in Pasadena.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top